Silica Storage Conditions: How to Store Silica to Prevent Moisture and Caking

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Powder Supplier Guide: How to Compare Grades, Quality and Pricing
  • Keywords: silica manufacturer
  • Published: 2026-11-20 08:58:41
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325

Silica Supplier Thailand: Market Overview and Sourcing Options

Thermal Conductive Filler: Silica vs Alumina vs Boron Nitride Compared
Lv, Z., He, S., Wang, Y. & Zhu, X. Noble metal nanomaterials for NIR‐triggered photothermal therapy in cancer. Adv. Healthc. Mater. 10, 2001806 (2021). Post CAS Google Scholar
Silica in Makeup Powder: Benefits for Oil Absorption and Blurring Effects
Liu, J. et al. Mesoporous silica coated single‐walled carbon nanotubes as a multifunctional light‐responsive platform for cancer combination therapy. Adv. Funct. Mater. 25, 384-392 (2015). Article CAS Google Scholar
What Is Silica Powder? Types, Particle Sizes, Grades and Common Applications
Novoray: Company Overview, Spherical Silica Products and Applications

What Is Hydrated Silica? Uses in Toothpaste, Cosmetics and Food Explained

What is silica (SiO₂)?

silica supplier Turkey Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61

What is the difference between fumed silica and precipitated silica?

is silica in toothpaste safe Vartuli, J. et al. Impact of surfactant/silica molar ratios on the formation of mesoporous molecular sieves: inorganic mimicry of surfactant liquid-crystal phases and mechanistic implications. Chem. Mater. 6, 2317-2326 (1994). Article CAS Google Scholar

What drives silica raw material prices?

silica for sealants Dynamic therapy refers to an emerging therapeutic modality in which nanosensitizers are activated in the presence of exogenous stimuli such as light, ultrasound and electric field or endogenous tiny molecules such as H 2 O 2, and sequentially induce the in situ production of toxic free radicals for damaging crucial cellular components (e.g., lipids, proteins or DNA), thus leading to cell apoptosis or necrosis. 400, 401 Typical dynamic therapy strategies contain photosensitizer-mediated PDT, sonosensitizer-mediated SDT, nanocatalyst-mediated CDT and electrodynamic therapy (EDT). 401 In dynamic therapy processes, MSNs are outstanding substrate materials for loading nanosensitizers, and their roles include enhancing nanosensitizer stability, cutting down potential toxicity, supplying a suitable microenvironment for chemical reactions, and acting as a therapeutic nanoplatform to integrate multifunctional components. For example, PDT is an oxygen-dependent therapeutic modality, and its therapeutic efficiency is affected by the oxygen concentration. Nonetheless, the tumor microenvironment or biofilm microenvironment are always characterized with hypoxia. 402, 403, 404 For this reason, the simultaneous integration of some components with oxygen-producing functions, such as catalase, 405, 406 MnO 2, 407, 408 and Pt NPs, 409, 410 into the pores or surfaces of MSNs is expected to enhance the photodynamic performance. Comparable to PDT, SDT is also a non-invasive therapeutic modality and many of sonosensitizers are originated from photosensitizers, 411 such as Mn protoporphyrin-encapsulated biodegradable MSNs for MRI-guided tumor SDT, 412 and IR-780 sonosensitizer-loaded hollow MSNs for SDT of pancreatic cancer. 413 Differently, an extremely unique feature in MSNs-based SDT is that MSNs themselves are potentially effective sonosensitizers with the talent to enhance ultrasound-induced cavitation effect, without the introduction of additional sonosensitizers. 414 The principal reason for this is that MSNs possess big amounts of hydrophobic mesopores that can serve as bubble nucleation seeds in response to low-intensity ultrasound. 415, 416 CDT exploits the sickness microenvironment to activate the Fenton/Fenton-like reaction to produce strongly oxidizing •OH for particular and targeted disease therapy, which is first recommended by Zhang et al. in 2016, 417 and has subsequently attracted much attention from researchers. 418, 419 The efficiency of CDT is closely related to the H 2 O 2 content in the disease microenvironment, so researches have focused on introducing functional factors on MSNs matrix to enhance the content of H 2 O 2 reactants, thus increasing the yield of •OH. In this regard, Li et al. encapsulated both ultra-small CaO 2 and Fe 3 O 4 NPs in dendritic MSNs. In the acidic tumor microenvironment, CaO 2 reacts with H + to produce large amounts of H 2 O 2, leading to the enhancement of Fe 3 O 4 -mediated Fenton reaction. 420 In another study, natural glucose oxidase was used to consume intratumoral glucose while producing additional H 2 O 2 for the subsequent Fenton reaction catalyzed by Fe 3 O 4 NPs. 421 Besides, EDT is an emerging therapeutic approach newly proposed in 2019. 422 In this pioneering work, Pt NPs, assisted by a square-wave alternating current electric field, induced the breakdown of water molecules on their surface to generate cytotoxic •OH, which effectively inhibited tumor cell proliferation and triggered tumor cell apoptosis. 422 Regarding the MSNs-based EDT, Gu et al. designed a Pt/MSNs nanocomplex for the first time and encapsulated DOX into MSNs pore channels, followed by a layer of chitosan to stop the premature drug release. Under the tumor microenvironment and alternating current electric field, the designed MSNs-based nanoplatform effectively removed large-sized tumors (over 500 mm 3 ) while ensuring minimal side influences. This work is the first study to combine EDT and chemotherapy, and it provided new insights into the development of MSNs-based EDT nanoplatforms. 141

Cite this article: Silica Raw Materials News. "Fumed Silica Manufacturer: Production Process, Key Grades and How to Choose ." Published 2026-11-20 08:58:41. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.